The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density

Journal of Orthopaedic Research

Volumn 29, Issue 3, 2011, Pages 414-418

  Butler, Joseph S ^a   Murray, David W ^a   Hurson, Conor J ^a   Obrien, Julie ^a   Doran, Peter P ^a   Obyrne, John M ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; WNT PROTEIN;

ARTICLE; BONE DENSITOMETRY; BONE DEVELOPMENT; BONE MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; HUMAN; LUMBAR ARTERY; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; SEROLOGY;

EID: 79251589954     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21260     Document Type: Article

References (29)

1. Hurson CJ, Butler JS, Keating DT, et al. 2007. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Musculoskelet Disord 8: 12.
2. Moon RT, Bowerman B, Boutros M, et al. 2002. The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646.
3. Pandur P, Maurus D, Kuhl M,. 2002. Increasingly complex: new players enter the Wnt signaling network. Bioessays 24: 881-884.
4. Logan CY, Nusse R,. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
5. Miller JR,. 2002. The Wnts. Genome Biol 3: reviews 3001.1-reviews 3001.15 [Epub December 28, 2001].
6. Gong YQ, Slee RB, Fukai N, et al. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
7. Gong YQ, Vikkula M, Boon L, et al. 1996. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet 59: 146-151.
8. Boyden LM, Mao JH, Belsky J, et al. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521.
9. Little RD, Carulli JP, Del Mastro RG, et al. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 11-19.
10. Van Wesenbeeck L, Cleiren E, Gram J, et al. 2003. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72: 763-771.
11. Moon RT, Kohn AD, De Ferrari GV, et al. 2004. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701.
12. Krishnan V, Bryant HU, Macdougald OA,. 2006. Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209.
13. Baron R, Rawadi G, Roman-Roman S,. 2006. Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol 76: 103-127.
14. Westendorf JJ, Kahler RA, Schroeder TM,. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341: 19-39.
15. Johnson ML, Harnish K, Nusse R, et al. 2004. LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19: 1749-1757 [Epub August 23, 2004].
16. Balemans W, Ebeling M, Patel N, et al. 2001. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10: 537-543.
17. Staehling-Hampton K, Proll S, Paeper BW, et al. 2002. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet 110: 144-152.
18. Bafico A, Liu GZ, Yaniv A, et al. 2001. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 3: 683-686.
19. Davidson G, Mao BY, Barrantes ID, et al. 2002. Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning. Development 129: 5587-5596.
20. Gregory CA, Singh H, Perry AS, et al. 2003. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278: 28067-28078.
21. Chu EY, Hens J, Andl T, et al. 2004. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 131: 4819-4829.
22. Kuhnert F, Davis CR, Wang HT, et al. 2004. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci USA 101: 266-271.
23. Li XF, Liu P, Liu WZ, et al. 2005. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 37: 945-952.
24. Tian E, Zhan FH, Walker R, et al. 2003. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483-2494.
25. Li J, Sarosi I, Cattley RC, et al. 2006. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39: 754-766 [Epub May 26, 2006].
26. Morvan F, Boulukos K, Clément-Lacroix P, et al. 2006. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945.
27. MacDonald BT, Joiner DM, Oyserman SM, et al. 2007. Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41: 331-339 [Epub June 5, 2007].
28. Rauner M, Sipos W, Pietschmann P,. 2008. Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation. Age (Dordr) 30: 273-282 [Epub September 2, 2008].
29. Almeida M, Han L, Martin-Millan M, et al. 2007. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282: 27298-27305 [Epub July 10, 2007].